Technical Success, Safety, and Short-term Efficacy for MR-Guided Laser Ablation of Prostate Bed Recurrences

Mayo Clinic1 site in 1 countryApril 2012

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Prostate Tumors
Sponsor: Mayo Clinic
Locations: 1
Primary Endpoint: Measurement of target lesion(s) dimensions at 3-6 month imaging follow-up
Status: Withdrawn
Last Updated: 12 years ago

The purpose of this study is to see if MR-guided laser ablation can effectively treat prostate tumor recurrences.

Registry

clinicaltrials.gov

Start Date

April 2012

End Date

February 2014

Last Updated

12 years ago

Study Type

Interventional

Study Design

Single Group

Sex

Male

Sponsor

Responsible Party

Principal Investigator

David A. Woodrum

Assistant Professor of Radiology, Mayo Clinic

Mayo Clinic

•Patients with "biopsy proven" soft tissue tumor recurrences of prostate fossa referred to Urology and/or Interventional Radiology for treatment.
•Surgery is not a desirable alternative therapy at the time of enrollment
•Radiation therapy has failed or not indicated or can be safely postponed
•Tumor size ≤ 5 cm at its largest diameter
•Tumor does not encompass the rectal wall or external urethral sphincter
•Performance status is ECOG 2 or better in adults
•Patient is able to undergo MRI